Corrigendum-Compounded mAbs - Cancer Therapies

The South East Pharmacy Procurement Service is issuing a recurring framework agreement for the supply and delivery of compounded monoclonal antibodies (mAbs) to be administered intravenously for chemo******* ************ *** ********* **** ** **** ********* ** ************* *** ****** ** *** ****** ****** ***** ****** *** ********** ***** ******** ******** *** *********** ** * ***** ** *********** *** ********** *** ******** ******* ********* ********** ********* *** **** ***** *** ******** ** *** ********* ** ******** ** ******** *** *********** ***** **** **** ********** **** ******** ** *** ****** ********* ***** ***** *********** ** ******* **** *** ******** ***** ***** ******** *********** ******** *** ********* **** ********* *** ********** ******** *** ****** ********* *** ***** ************ ***** ****** ************ ******** *** ******** ******** ******** *** ********** ***** ******** *** ***** ** ** ********* **** **** ***** ******* *** ** ** *** ******** *********** ********** *** ******** ** *** *** * ******* ** **** ****** *** ********** ** ****** **** ********* ********* *********** ******* ********* *** ***** ***** **** * ********** ****** ** *** ****** *** ******** ** ***** *** ****** ********* ***** ***** ******** **** **** **** ******* *** ******** ****** *** ******* *********** **********